Home›Stock Screener›Beta Drugs›Market Cap

Beta Drugs Market Cap ($222.71M USD)

Market Cap ₹2004.38 Cr $222.71M USD As of November 2026

Beta Drugs Market Cap ($222.71M USD). As of Nov. 19, 2026, Beta Drugs (BETA) market capitalisation is ₹2004.38 Cr ($222.71M), with 1.14 Cr shares outstanding at a current price of ₹1764.20 on NSE, ranking 1166 out of 5368 companies by market cap in our screener. Beta Drugs operates in the Healthcare sector and is classified as a Small Cap stock. Review Beta Drugs P/E valuation to evaluate earnings-based valuation against sector peers.

Current Price
₹1764.20
Outstanding Shares
1.14 Cr
Market Cap Rank
#1166
Top Percentile
78.3%

Market Cap History of Beta Drugs (Last 10 Years)

BETA market capitalisation from year-end NSE closing prices over the last 10 years.

End of Year Market Cap History — Beta Drugs

BETA year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see Beta Drugs share price chart.

Year Market Cap Share Price Exchange Change
2026
₹2004.38 Cr $222.71M USD
₹1764.20 NSE +13.89%
2025
₹1760.00 Cr $195.56M USD
₹1549.10 NSE -

Market Cap Data Sources

Tickjournal (INR) ₹2004.38 Cr
Tickjournal (USD) $222.71M
Price Source NSE
USD to INR Rate ₹90.00